Privia Health Group, Inc. (NASDAQ:PRVA) Shares Purchased by GSA Capital Partners LLP

GSA Capital Partners LLP boosted its position in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 228.1% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 50,975 shares of the company's stock after purchasing an additional 35,439 shares during the period. GSA Capital Partners LLP's holdings in Privia Health Group were worth $928,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also modified their holdings of PRVA. Canada Pension Plan Investment Board bought a new stake in shares of Privia Health Group during the second quarter valued at approximately $26,000. GAMMA Investing LLC increased its holdings in Privia Health Group by 98.7% during the 3rd quarter. GAMMA Investing LLC now owns 1,701 shares of the company's stock worth $31,000 after purchasing an additional 845 shares during the period. Nisa Investment Advisors LLC raised its position in Privia Health Group by 107.5% during the 2nd quarter. Nisa Investment Advisors LLC now owns 1,795 shares of the company's stock valued at $31,000 after purchasing an additional 930 shares in the last quarter. Signaturefd LLC lifted its holdings in shares of Privia Health Group by 46.3% in the 2nd quarter. Signaturefd LLC now owns 1,978 shares of the company's stock worth $34,000 after buying an additional 626 shares during the period. Finally, Values First Advisors Inc. purchased a new position in shares of Privia Health Group during the third quarter valued at $83,000. Hedge funds and other institutional investors own 94.48% of the company's stock.

Insider Buying and Selling at Privia Health Group

In related news, CEO Parth Mehrotra sold 135,142 shares of the company's stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $18.50, for a total transaction of $2,500,127.00. Following the completion of the transaction, the chief executive officer now owns 247,771 shares in the company, valued at $4,583,763.50. This represents a 35.29 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 14.20% of the stock is currently owned by corporate insiders.

Privia Health Group Price Performance

NASDAQ:PRVA traded down $0.49 during mid-day trading on Friday, hitting $21.20. The company's stock had a trading volume of 817,403 shares, compared to its average volume of 868,711. The business's fifty day moving average is $18.71 and its two-hundred day moving average is $18.49. The stock has a market cap of $2.54 billion, a price-to-earnings ratio of 212.00, a PEG ratio of 5.07 and a beta of 0.76. Privia Health Group, Inc. has a 1 year low of $15.92 and a 1 year high of $24.30.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on PRVA shares. Barclays boosted their price objective on shares of Privia Health Group from $19.00 to $21.00 and gave the stock an "equal weight" rating in a research note on Friday, November 8th. Royal Bank of Canada reaffirmed an "outperform" rating and set a $28.00 price objective on shares of Privia Health Group in a research report on Wednesday, August 14th. KeyCorp began coverage on shares of Privia Health Group in a report on Friday, October 11th. They issued an "overweight" rating and a $23.00 target price for the company. Robert W. Baird raised their price target on shares of Privia Health Group from $23.00 to $24.00 and gave the company an "outperform" rating in a report on Monday, August 26th. Finally, Truist Financial boosted their price objective on shares of Privia Health Group from $24.00 to $27.00 and gave the stock a "buy" rating in a research note on Friday, November 8th. Two analysts have rated the stock with a hold rating, twelve have assigned a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, Privia Health Group currently has an average rating of "Buy" and a consensus target price of $25.07.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.